(ADMA) ADMA Biologics - Performance 57.7% in 12m
ADMA performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
76.89%
#3 in Peer-Group
Rel. Strength
87.24%
#947 in Stock-Universe
Total Return 12m
57.66%
#20 in Peer-Group
Total Return 5y
530.10%
#2 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 21.6 |
| P/E Forward | 29.0 |
| High / Low | USD |
|---|---|
| 52 Week High | 24.51 USD |
| 52 Week Low | 11.18 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 15.11 |
| Buy/Sell Signal +-5 | -0.07 |
| Support / Resistance | Levels |
|---|---|
| Support | 17.1, 13.6 |
| Resistance | 22.2, 19.6 |
12m Total Return: ADMA (57.7%) vs XBI (-10.8%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
2.52% | 66.7% | 77.4% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-11.7% | -9.92% | 139% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-3.21% | -7.33% | 26.4% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
-0.28% | 31.9% | -4.56% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
0.91% | -10.3% | 0.26% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.3% | 65.1% | -9.72% | 25.5 | 22.8 | 0.91 | 48.1% | 3.93% |
| PTCT NASDAQ PTC Therapeutics |
0.02% | 56.7% | -7.85% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
2.86% | 34.5% | 14.3% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ADMA vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ADMA
| Total Return (including Dividends) | ADMA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -10.87% | 2.09% | 4.55% |
| 3 Months | -8.22% | 2.27% | 10.78% |
| 12 Months | 57.66% | -10.84% | 14.71% |
| 5 Years | 530.10% | -26.24% | 112.53% |
| Trend Score (consistency of price movement) | ADMA | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -62.5% | 18.8% | 79.2% |
| 3 Months | -22.9% | 71.5% | 92.9% |
| 12 Months | 53.6% | -84.3% | 44.2% |
| 5 Years | 86.3% | -52.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th24.50 | -12.69% | -14.75% |
| 3 Month | %th42.00 | -10.25% | -17.15% |
| 12 Month | %th90.50 | 76.83% | 37.45% |
| 5 Years | %th99.50 | 754.32% | 196.48% |
FAQs
Does ADMA Biologics (ADMA) outperform the market?
Yes,
over the last 12 months ADMA made 57.66%, while its related Sector, the SPDR S&P Biotech (XBI) made -10.84%.
Over the last 3 months ADMA made -8.22%, while XBI made 2.27%.
Performance Comparison ADMA vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ADMA vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -1.1% | -15.4% | 0.1% | 43% |
| US NASDAQ 100 | QQQ | -1.9% | -16.4% | -2% | 43% |
| German DAX 40 | DAX | -0.9% | -10.9% | -12.8% | 28% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.7% | -15% | 2.1% | 40% |
| Hongkong Hang Seng | HSI | -0.6% | -16.7% | -15.6% | 22% |
| India NIFTY 50 | INDA | -0.6% | -13% | 0.4% | 58% |
| Brasil Bovespa | EWZ | -2.4% | -18.6% | -24.4% | 44% |
ADMA vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2.6% | -17.6% | -6.5% | 29% |
| Consumer Discretionary | XLY | 0.5% | -12.5% | 8.8% | 38% |
| Consumer Staples | XLP | 2.4% | -9.2% | 1.9% | 48% |
| Energy | XLE | 3.3% | -14.4% | 5.6% | 62% |
| Financial | XLF | -1.2% | -14% | -3% | 29% |
| Health Care | XLV | -0.1% | -12.9% | 7.4% | 63% |
| Industrial | XLI | -0.6% | -14.6% | -6.5% | 34% |
| Materials | XLB | 0.9% | -12.5% | 0.8% | 55% |
| Real Estate | XLRE | 3.4% | -10.9% | 2.8% | 45% |
| Technology | XLK | -2.4% | -19.8% | -3.1% | 46% |
| Utilities | XLU | 1.4% | -10.9% | -3.2% | 33% |
| Aerospace & Defense | XAR | -3% | -20.7% | -21.3% | 5% |
| Biotech | XBI | 1.1% | -13% | 14.1% | 69% |
| Homebuilder | XHB | 0.7% | -17% | 11.4% | 57% |
| Retail | XRT | 2% | -12.3% | 8.9% | 52% |
ADMA vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 6.2% | -16.0% | 9.41% | 68% |
| Natural Gas | UNG | 11.2% | -1.4% | 15.3% | 65% |
| Gold | GLD | 3.9% | -8.7% | -19.7% | 16% |
| Silver | SLV | 2.4% | -14.7% | -18.4% | 35% |
| Copper | CPER | -1.3% | -15.1% | -19.6% | 42% |
ADMA vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 0.2% | -14.5% | 3.3% | 56% |
| iShares High Yield Corp. Bond | HYG | 1% | -12.7% | 1.2% | 47% |